about
Rapid countermeasure discovery against Francisella tularensis based on a metabolic network reconstructionPrediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization processA network-based multi-target computational estimation scheme for anticoagulant activities of compoundsSignalogs: orthology-based identification of novel signaling pathway components in three metazoansLinking proteins to signaling pathways for experiment design and evaluationIntegrating findings of traditional medicine with modern pharmaceutical research: the potential role of linked open dataAdvances in structure elucidation of small molecules using mass spectrometryMycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance.GPCRs, G-proteins, effectors and their interactions: human-gpDB, a database employing visualization tools and data integration techniques.Identification of small molecules enhancing autophagic function from drug network analysis.Elucidating polypharmacological mechanisms of polyphenols by gene module profile analysis.Discovery of drug mode of action and drug repositioning from transcriptional responses.DTome: a web-based tool for drug-target interactome construction.SignaLink 2 - a signaling pathway resource with multi-layered regulatory networksElucidating pharmacological mechanisms of natural medicines by biclustering analysis of the gene expression profile: a case study on curcumin and Si-Wu-Tang.Identification of novel peroxisome proliferator-activated receptor-gamma (PPARγ) agonists using molecular modeling method.Are predicted protein structures of any value for binding site prediction and virtual ligand screening?Combining rules and machine learning for extraction of temporal expressions and events from clinical narratives.A Perspective on Computational Chemogenomics.Exploring consumer exposure pathways and patterns of use for chemicals in the environment.Mining small-molecule screens to repurpose drugs.Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses
P2860
Q27678284-AE71FD22-9E0C-4E6A-AB07-A3401A1A2A63Q27902343-B158DB0F-9FF9-47E9-ADCD-7D340BE16065Q28477458-68C1ADD1-0ACB-451F-929E-CA76D313B881Q28478034-F69C0595-C379-4844-8856-B739EEDCD927Q28482688-F1020DF4-4419-4D7D-8006-C15E603D167BQ28743666-B3B01B3F-D1B0-49AD-BEF5-A9D3E982AAC3Q28743720-3A03D3CC-D2E0-4C52-A7EA-1DA365EBF6DBQ33395486-776218F1-2AC1-42AE-A2CD-B2A0986E4EB2Q33650740-68997238-C235-4656-8FFB-B17CB7E27530Q33712703-28EADA92-7E8C-4EAC-898C-8C4EEA1B6FCCQ34072162-AD450D09-13AF-4FB6-A9F2-59C4775B1D8DQ34093341-73FD867F-323B-44BD-A80F-66E552303B95Q34383264-BEE3945E-38F7-4955-8FF6-7A6D96BD91ACQ34554087-5F2590E0-31D5-4C96-86F5-2E6C6AD73B0CQ35016460-DF2589E7-52F7-4615-A265-32C6C094D95DQ35234394-057403FF-8B60-4394-AAB9-186FBD950C8AQ36859642-8B579F17-61DE-4AF7-AC75-A85DBD528840Q37129531-2E73DA4A-5B9A-457A-A842-437F24BAE615Q39535946-C871BEE0-23DA-4293-AC0E-4E81C7E2B9C4Q41680675-0A303642-7C36-4F9B-B4A5-C0C146D848FDQ47583144-C4743946-CAD6-427B-84F3-D2EF591E7255Q57069450-B914BDD6-8A90-4ED5-9DB8-A2C51AC114E0
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
DrugBank and its relevance to pharmacogenomics.
@en
DrugBank and its relevance to pharmacogenomics.
@nl
type
label
DrugBank and its relevance to pharmacogenomics.
@en
DrugBank and its relevance to pharmacogenomics.
@nl
prefLabel
DrugBank and its relevance to pharmacogenomics.
@en
DrugBank and its relevance to pharmacogenomics.
@nl
P2860
P1433
P1476
DrugBank and its relevance to pharmacogenomics.
@en
P2860
P304
P356
10.2217/14622416.9.8.1155
P577
2008-08-01T00:00:00Z